DCP1A

DCP1A Full Name

decapping mRNA 1A

DCP1A Introduction

DCP1A encodes the mRNA decapping protein 1a, a central component of the machinery that degrades messenger RNAs from their 5' end. Messenger RNA decay is a major determinant of gene expression, because the abundance of every transcript reflects the balance between its synthesis and its destruction, and cells use regulated mRNA decay both to remove damaged or unwanted transcripts and to adjust gene expression rapidly in response to signals. The first and irreversible step of the major 5'-to-3' mRNA decay pathway is the removal of the 5' cap structure, and this reaction is catalyzed by the decapping enzyme DCP2 working together with a set of accessory proteins, of which DCP1A is the most important activator in human cells. DCP1A enhances the activity of DCP2 and helps recruit the decapping complex to its substrates, and the complex operates within processing bodies, cytoplasmic granules where mRNAs destined for decay or storage are concentrated. By controlling the efficiency of decapping, DCP1A influences the stability of thousands of mRNAs and thereby shapes the expression of proteins involved in cell proliferation, differentiation, stress responses, and inflammation. Consistent with this broad influence, DCP1A has been linked to tumor cell behavior and to the regulation of immune responses, and its study has illuminated how the post-transcriptional control of mRNA stability contributes to cellular physiology.

Figure 1. The structure of DCP1A.

Decapping Complex Assembly and the EVH1 Scaffold Domain
DCP1A is a member of the DCP1 family of decapping activators, and its N-terminal region contains an EVH1 (Ena/VASP homology 1) domain that mediates protein-protein interactions.
The EVH1 domain of DCP1A binds to proline-rich sequences in partner proteins, most notably the decapping enzyme DCP2 and the scaffold protein EDC4, tethering the components of the decapping complex together.
DCP1A also interacts with additional regulators of mRNA decay, including proteins that link the decapping machinery to translation repression and to microRNA-mediated silencing.
The decapping reaction itself is catalyzed by DCP2, which cleaves the 5' cap to release m7GDP; DCP1A and its binding partners stimulate this activity by several orders of magnitude.
The DCP1A gene is located on human chromosome 3, and the protein is distributed throughout the cytoplasm with enrichment in processing bodies.
Processing bodies are dynamic assemblies that contain the decapping machinery together with stored or translationally silenced mRNAs, and their size and number change with the metabolic state of the cell.
Phosphorylation of DCP1A and its partners regulates the assembly of the decapping complex and the rate of mRNA decay in response to cellular signals.

mRNA Turnover, Cellular Stress, and Links to Disease
The 5'-to-3' mRNA decay pathway, controlled by the DCP1A-DCP2 complex, is responsible for the degradation of a large fraction of cellular mRNAs and is essential for the rapid remodeling of gene expression that follows a change in cell state.
After deadenylation shortens the poly(A) tail, the decapping complex removes the cap, exposing the transcript to the 5'-to-3' exonuclease XRN1, which completes the destruction of the mRNA.
The decapping machinery is intimately connected to translation: mRNAs that are poorly translated are preferentially directed into processing bodies and decapped, so DCP1A activity helps enforce the coupling between translational status and mRNA stability.
During cellular stress, the redistribution of DCP1A and its partners into larger processing bodies contributes to the global repression of protein synthesis and the selective expression of stress-response genes.
Dysregulation of decapping has been reported in cancer, where altered mRNA stability can change the expression of oncogenes and tumor suppressors, and DCP1A levels have been found to influence the growth and survival of tumor cells in experimental systems.
Because the decapping complex acts on many transcripts simultaneously, it represents a potentially powerful but challenging target for therapeutic manipulation of gene expression.

Alternate Names for DCP1A

DCP1A; decapping mRNA 1A; SMIF; SMAD4IP1; HSA275986; Nbla00360; mRNA-decapping enzyme 1A; decapping enzyme hDcp1a; transcription factor SMIF; DCP1 decapping enzyme homolog A; putative protein product of Nbla00360; Smad4-interacting transcriptional co-activator;